WHO ICTRP trial
A randomized, controlled, open-label, multicenter Phase III clinical study of…
ChiCTR2500113348 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113348 |
|---|---|
| Public title | A randomized, controlled, open-label, multicenter Phase III clinical study of liposomal irinotecan hydrochloride injection (II) combined with oxaliplatin, 5-fluorouracil, and calcium folinate versus albumin-bound paclitaxel combined with gemcitabine as first-line treatment for advanced pancreatic cancer |
| Scientific title | A randomized, controlled, open-label, multicenter Phase III clinical study of liposomal irinotecan hydrochloride injection (II) combined with oxaliplatin, 5-fluorouracil, and calcium folinate versus albumin-bound paclitaxel combined with gemcitabine as first-line treatment for advanced pancreatic… |
| Primary sponsor | Peking Union Medical College Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Patients with metastatic pancreatic cancer who have not received any systemic antitumor treatment during the metastatic stage. |
| Interventions | Control group:Gemcitabine 1000 mg/m2 + nab-paclitaxel 125 mg/m2 on Days 1, 8, and 15; one treatment cycle every 4 weeks.;Trial group:Liposomal irinotecan hydrochloride (II) 60 mg/m^2 + oxaliplatin 85 mg/m^2 + 5-FU/LV 2400/400 mg/m^2 IV on… |
| Registration date | Nov 27, 2025 |
| Target size | Control group:331;Trial group:331 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: